ILOPERA

Welcome to the Brand page for “ILOPERA”, which is offered here for Pharmaceuticals, medical and veterinary preparations for improving exercise capacity and symptoms in nyha iii and iv patients with primary (idiopathic and familial) pulmonary hypertension and with pulmonary hypertension due to scleroderma without co-existing interstitial pulmonary and for treatment of patients with advanced thromboangitis obliterans (buerger's disease) with critical limb ischemia in whom revascularization is not indicated, treatment of patients with severe peripheral arterial occlusive disease (paod), particularly in cases who carry a risk of amputation or cannot undergo angioplasty, treatment of patients with raynaud's phenomenon irresponsive to other treatments and causing severe restriction; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary medical use, food for babies; dietary supplements for humans and animals; medical plasters, and materials for medical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ILOPERA” is believed to be currently owned by “GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI”.


Owner:
GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
Owner Details
Description:
Pharmaceuticals, medical and veterinary preparations for improving exercise capacity and symptoms in NYHA III and IV patients with Primary (idiopathic and familial) pulmonary hypertension and with Pulmonary hypertension due to scleroderma without co-existing interstitial pulmonary and for treatment of patients with advanced Thromboangitis obliterans (Buerger's disease) with critical limb ischemia in whom revascularization is not indicated, treatment of patients with severe peripheral arterial occlusive disease (PAOD), particularly in cases who carry a risk of amputation or cannot undergo angioplasty, treatment of patients with Raynaud's phenomenon irresponsive to other treatments and causing severe restriction; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary medical use, food for babies; dietary supplements for humans and animals; medical plasters, and materials for medical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides;Color is not claimed as a feature of the mark.;
Categories: PHARMACEUTICALS